CTLT vs. AZN
Compare and contrast key facts about Catalent, Inc. (CTLT) and AstraZeneca PLC (AZN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CTLT or AZN.
Key characteristics
| CTLT | AZN | |
|---|---|---|
| YTD Return | 24.30% | 14.40% |
| 1Y Return | 11.43% | 5.51% |
| 3Y Return (Ann) | -20.86% | 15.27% |
| 5Y Return (Ann) | 4.70% | 18.03% |
| Sharpe Ratio | 0.23 | 0.27 |
| Daily Std Dev | 50.53% | 22.23% |
| Max Drawdown | -77.62% | -48.94% |
| Current Drawdown | -60.77% | 0.00% |
Fundamentals
| CTLT | AZN | |
|---|---|---|
| Market Cap | $10.12B | $233.06B |
| EPS | -$7.18 | $2.02 |
| PE Ratio | 207.70 | 37.21 |
| PEG Ratio | 2.06 | 0.89 |
| Revenue (TTM) | $4.10B | $47.61B |
| Gross Profit (TTM) | $1.04B | $35.73B |
| EBITDA (TTM) | $327.00M | $15.80B |
Correlation
The correlation between CTLT and AZN is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CTLT vs. AZN - Performance Comparison
In the year-to-date period, CTLT achieves a 24.30% return, which is significantly higher than AZN's 14.40% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CTLT vs. AZN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalent, Inc. (CTLT) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CTLT vs. AZN - Dividend Comparison
CTLT has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 1.91%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTLT Catalent, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AZN AstraZeneca PLC | 1.91% | 2.15% | 2.14% | 2.40% | 2.80% | 2.81% | 3.61% | 3.95% | 5.01% | 4.06% | 3.98% | 4.72% |
Drawdowns
CTLT vs. AZN - Drawdown Comparison
The maximum CTLT drawdown since its inception was -77.62%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for CTLT and AZN. For additional features, visit the drawdowns tool.
Volatility
CTLT vs. AZN - Volatility Comparison
The current volatility for Catalent, Inc. (CTLT) is 2.36%, while AstraZeneca PLC (AZN) has a volatility of 6.06%. This indicates that CTLT experiences smaller price fluctuations and is considered to be less risky than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CTLT vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Catalent, Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities